SJM
38
-3
PNW
66
3
ORLY
57
-3
IVZ
50
-3
IPG
39
-3
SO
66
2
IP
39
-6
IBM
81
3
RF
51
-2
VZ
47
2
PRGO
44
-2
ESS
60
-8
TDC
59
10
AMG
41
-3
ADP
69
-3
KMI
59
2
VRSK
35
-3
INTU
63
-2
DE
53
8
BAX
30
-3
SJM
38
-3
PNW
66
3
ORLY
57
-3
IVZ
50
-3
IPG
39
-3
SO
66
2
IP
39
-6
IBM
81
3
RF
51
-2
VZ
47
2
PRGO
44
-2
ESS
60
-8
TDC
59
10
AMG
41
-3
ADP
69
-3
KMI
59
2
VRSK
35
-3
INTU
63
-2
DE
53
8
BAX
30
-3
Financhill
Back

Global X Eql Wgt Canadian Bk Cov Cll ETF Vs. Apellis Pharmaceuticals Industry Stock Comparison

Sell
34

BKCC.TO
Global X Eql Wgt Canadian Bk Cov Cll ETF

Last Price:
14.65
Seasonality Move:
-0.21%
Sell
19

APLS
Apellis Pharmaceuticals

Last Price:
32.49
Seasonality Move:
18.8%
Sell
34
Global X Eql Wgt Canadian Bk Cov Cll ETF (BKCC.TO) is a Sell

Is Global X Eql Wgt Canadian Bk Cov Cll ETF a Buy, Sell or Hold?

  • The current Global X Eql Wgt Canadian Bk Cov Cll ETF [BKCC.TO] share price is $14.65. The Score for BKCC.TO is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • BKCC.TO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
19
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $32.50. The Score for APLS is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

BKCC.TO Stock Price Chart

What is Global X Eql Wgt Canadian Bk Cov Cll ETF's stock price today?

  • The Global X Eql Wgt Canadian Bk Cov Cll ETF share price today is $14.65
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BKCC.TO is experiencing buying pressure, which is a positive indicator for future bullish movement.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $32.50
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing slight selling pressure.

BKCC.TO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.2 Buy
Relative Strength Index (14 RSI): 80.09 Buy
Chaikin Money Flow: 14462 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (13.96 - 14.46) Buy
Bollinger Bands (100): (13.51 - 14.17) Buy

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.84 Sell
Relative Strength Index (14 RSI): 33.6 Sell
Chaikin Money Flow: -1084788 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (36.37 - 40.01) Sell
Bollinger Bands (100): (36.55 - 42.35) Sell

BKCC.TO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 14.53 Buy
20-day SMA: 14.29 Buy
50-day SMA: 13.95 Buy
200-day SMA: 13.93 Buy
8-day EMA: 14.52 Buy
20-day EMA: 14.32 Buy
50-day EMA: 14.06 Buy
200-day EMA: 13.97 Buy

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 36.19 Sell
20-day SMA: 38.04 Sell
50-day SMA: 37.88 Sell
200-day SMA: 50 Sell
8-day EMA: 35.96 Sell
20-day EMA: 37.21 Sell
50-day EMA: 38.25 Sell
200-day EMA: 45.7 Sell

Global X Eql Wgt Canadian Bk Cov Cll ETF Earnings Growth & BKCC.TO Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.74 per share, an increase next quarter of $0.23 per share, an increase this year of $3.28 per share, and an increase next year of $1.34 per share.

Global X Eql Wgt Canadian Bk Cov Cll ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):